Back
Cell Cover Issue: Li Ji Biology's 2024 Success ChartScholarship ProgramOpen now, all in the published literatureIndicate the use of Li Ji BiotechnologyIf the product meets the requirements and the influencing factors are met, the scholarship can be applied for.
Thank you very much for your support and understanding over the past year. Li Ji Biology will continue to assist in scientific research and work together with you to achieve success in the new year. Wishing all researchers a prosperous year in 2024，Future prospects, paper releases, IF rises and rises!
1、 Reward Standards
2、 Precautions
1、The applicant must beFirst author，And indicate in the article that the product was purchased fromHeyuan Liji (Shanghai) Biotechnology Co., Ltd，Our English name is“Shanghai Life-iLab Biotech Co., Ltd”、“Life-iLab, China”or“Life-iLab, Shanghai, China”。
for example：AC11L054-Cell Counting Kit-8 (Life-iLab, Shanghai, China)；
2、The impact factor (IF) should be based on the scholarship application, and the article should have a DOI number; Applying for a scholarship is considered as authorization and official commercial promotion for the citation and interpretation of Yuan Li Ji's literature. The author is required to provide the full text of the article (in PDF format)；
3、Each article can only be applied for once, and if the applicant publishes multiple articles using the same product, it can only be redeemed once; The application time isFrom January 1, 2024 to December 31, 2024。Applicants should ensure the authenticity and validity of the submitted information. If they submit false information, impersonate the original author's identity, or have their manuscript revoked due to plagiarism or fraud, the applicant shall refund all scholarships and bear all relevant legal responsibilities;
4、Applicants need to cooperate with the staff to submit the necessary documents for applying for scholarships,Please contact the relevant salesperson for application and consultatioOr click to fill out the application form. The final interpretation of the event belongs to Heyuan Liji (Shanghai) Biotechnology Co., Ltd.
3、 Previous paper presentation
Partial display
(The above images are taken from the journal)
paper1：Local hyperthermia therapy induces browning of white fat and treats obesity
periodical：Cell Cover Issue
Influencing factors：41.582
Publication time：March 5, 2022
Using Li Ji products:
Product name：EZ Trans Cell Transfection Reagent (Efficient)
Item number：AC04L091/AC04L092
(The above images are taken from the journal)
paper2：Large-Scale Multiplexed Mosaic CRISPR Perturbation in the Whole Organism
periodical：Cell
Influencing factors：66.850
Publication time：July 22, 2022
Using Li Ji products:
Product name：EZ Trans Cell Transfection Reagent (Efficient)
Item number：AC04L091/AC04L092
(The above images are taken from the journal)
Paper3：Dietary ketone body-escalated histone acetylation in megakaryocytes alleviates chemotherapy-induced thrombocytopenia
Journal：STM Cover Issue
Impact factor：19.319
Publication time：November 30, 2022
Using Li Ji products:
Product name：EZ PCR direct expansion mouse tail lysate
Item number：AN11L227/AN11L228
(The above images are taken from the journal)
Paper 4：Brown-fat-mediated tumour suppression by cold-altered global metabolism
Journal：Nature
Impact factor：69.504
Published onUsing Li Ji products：
Product Name：EZ ECL Pico Chemiluminescence Liquid (Ultra Sensitive Type)
Item number：AP34L024/AP34L025
Heyuan Liji is a domestic biological reagent company established in 2023 through a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, integrating research and development, production, and sales. It focuses on the fields of life sciences and biotechnology, and is committed to providing customers with advanced technology, convenient and easy-to-use, and cost-effective products. Its product range includes experimental reagents and reagent kits related to cell biology, molecular biology, immunology, and biochemistry.
Currently, authorized agents are available in over 40 cities across the country; There are over a thousand direct service terminals, covering CROs, pharmaceutical companies, universities, hospitals, and research institutes; Li Ji's products have helped clients publish hundreds of SCI papers and multiple CNS papers.
